Literature DB >> 31573664

Ulceration in Prolidase Deficiency: Successful Treatment with Anticoagulants.

Kira Süßmuth1, Dieter Metze, Ana-Maria Muresan, Kai Lehmberg, Udo Zur Stadt, Carsten Speckmann, Julien Heinrich Park, Thorsten Marquardt, Vinzenz Oji, Tobias Goerge.   

Abstract

Entities:  

Keywords:  livedoid vasculopathy; prolidase deficiency; ulceration

Mesh：

Substances：

Year:  2020        PMID： 31573664      PMCID： PMC9128920          DOI： 10.2340/00015555-3324

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  10 in total

Review 1.  Livedoid vasculopathy - a thrombotic disease.

Authors:  Nina Kerk; Tobias Goerge
Journal:  Vasa       Date:  2013-09       Impact factor: 1.961

2.  A rare cause of cutaneous ulceration: Prolidase deficiency.

Authors:  Artoghrul Lsazade; Gonca Elçin; Sibel Doğan; Duygu Gülseren; Özay Gököz; Berrak Gürbüz; Diclehan Orhan; Serap Sivri; Ayşen Karaduman
Journal:  Int Wound J       Date:  2019-05-14       Impact factor: 3.315

3.  Hyperbaric oxygen therapy in the management of severe leg ulcers from prolidase deficiency.

Authors:  Michelangelo Vestita; Giuseppe Giudice; Domenico Bonamonte
Journal:  BMJ Case Rep       Date:  2017-01-06

4.  Structural basis for prolidase deficiency disease mechanisms.

Authors:  Piotr Wilk; Monika Uehlein; Rafal Piwowarczyk; Holger Dobbek; Uwe Mueller; Manfred S Weiss
Journal:  FEBS J       Date:  2018-08-14       Impact factor: 5.542

5.  Prolidase deficiency breaks tolerance to lupus-associated antigens.

Authors:  Biji T Kurien; Anil D'Sousa; Benjamin F Bruner; Timothy Gross; Judith A James; Ira N Targoff; Jacen S Maier-Moore; Isaac T W Harley; Heng Wang; R Hal Scofield
Journal:  Int J Rheum Dis       Date:  2013-12-14       Impact factor: 2.454

6.  Immune function in prolidase deficiency.

Authors:  M A Cleary; M Heaney; J M Couriel; J H Walter
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

7.  Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial.

Authors:  Carsten Weishaupt; Anke Strölin; Birgit Kahle; Alexander Kreuter; Stefan W Schneider; Joachim Gerss; Maria Eveslage; Attyla Drabik; Tobias Goerge
Journal:  Lancet Haematol       Date:  2016-01-16       Impact factor: 18.959

8.  Four novel PEPD alleles causing prolidase deficiency.

Authors:  P Ledoux; C Scriver; P Hechtman
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

9.  Substrate specificity and reaction mechanism of human prolidase.

Authors:  Piotr Wilk; Monika Uehlein; Jacqueline Kalms; Holger Dobbek; Uwe Mueller; Manfred S Weiss
Journal:  FEBS J       Date:  2017-08-08       Impact factor: 5.542

10.  A plasma proteolysis pathway comprising blood coagulation proteases.

Authors:  Lu Yang; Yun Li; Arup Bhattacharya; Yuesheng Zhang
Journal:  Oncotarget       Date:  2016-07-05
  10 in total
  2 in total

1.  Prolidase deficiency, a rare inborn error of immunity, clinical phenotypes, immunological features, and proposed treatments in twins.

Authors:  Nora Alrumayyan; Drew Slauenwhite; Sarah M McAlpine; Sarah Roberts; Thomas B Issekutz; Adam M Huber; Zaiping Liu; Beata Derfalvi
Journal:  Allergy Asthma Clin Immunol       Date:  2022-02-23       Impact factor: 3.406

2.  Quantitative analysis of the natural history of prolidase deficiency: description of 17 families and systematic review of published cases.

Authors:  Francis Rossignol; Marvid S Duarte Moreno; Carlos R Ferreira; Manuel Schiff; Jean-François Benoist; Manfred Boehm; Emmanuelle Bourrat; Aline Cano; Brigitte Chabrol; Claudine Cosson; José Luís Dapena Díaz; Arthur D'Harlingue; David Dimmock; Alexandra F Freeman; María Tallón García; Cheryl Garganta; Tobias Goerge; Sara S Halbach; Jan de Laffolie; Christina T Lam; Ludovic Martin; Esmeralda Martins; Andrea Meinhardt; Isabelle Melki; Amanda K Ombrello; Noémie Pérez; Dulce Quelhas; Anna Scott; Anne M Slavotinek; Ana Rita Soares; Sarah L Stein; Kira Süßmuth; Jenny Thies
Journal:  Genet Med       Date:  2021-05-26       Impact factor: 8.822
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.